'To CT or not to CT? That is the question': Outcome surrogates for surveillance in childhood cystic fibrosis

Thorax

Volumn 67, Issue 6, 2012, Pages 471-472

  Young, Carolyn ^a   Owens, Catherine ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

BRONCHIECTASIS; CANCER RISK; CFTR GENE; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DISEASE SURVEILLANCE; EDITORIAL; GENOTYPE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG CLEARANCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RISK BENEFIT ANALYSIS; SPIROMETRY; THORAX RADIOGRAPHY;

BRONCHIECTASIS; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FORCED EXPIRATORY VOLUME; HUMANS; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PULMONARY GAS EXCHANGE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; UNNECESSARY PROCEDURES;

EID: 84861907602     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-201549     Document Type: Editorial

References (12)

1. Brody AS, Sucharew H, Campbell JD, et al. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 2005;172:1128-32. (Pubitemid 43066648)
2. Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using computed tomography. Thorax 2012;67:509-16
3. Owens CM, Aurora P, Stanojevic S, et al. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011;66:481-8.
4. Dinwiddie R. Lung function testing in infants. Allergol Immunopathol (Madr) 2010;38:337-40.
5. Ellemunter H, Fuchs SI, Unsinn KM, et al. Sensitivity of lung clearance index and chest CT in early CF lung disease. Respir Med 2010;104:1834-42.
6. de Gonzales AB, Kim KP, Samet JM. Radiation-induced cancer risk from annual CT for patients with CF. Am J Respir Crit Care Med 2007;176:970-3. (Pubitemid 350127839)
7. Johannesson M, Askling J, Montgomery SM, et al. Cancer risk among patients with cystic fibrosis and their first degree relatives. Int J Cancer 2009;125:2953-6.
8. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive CT scanning. Am J Respir Crit Care Med 2006;173:199-203. (Pubitemid 43187892)
9. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with CF and the G551D mutation. N Engl J Med 2011;365:1663-72.
10. Clancy JP, Rowe SM, Accurso FJ, et al. Results of a phase IIa study VX-809, an investigational CFRT corrector compound, in subjects with CF homozygous for the F508del-CFTR mutation. Thorax 2012;67:12-18.
11. Loeve M, Lequin MH, de Bruijne M, et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease? Radiology 2009;253:223-9.
12. Gustaffson PM, De Jong PA, Tiddens HA. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008;63:129-34. (Pubitemid 351236476)